| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Ovary; Carcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS809684 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Ovary; Carcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS809685 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Ovary; Carcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS811297 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Ovary; Carcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS814067 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Ovary; Carcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS627904 | 5x5um | ORIGENE TECHNOLOGIES |
| Complement factor B (CFB) from ORIGENE TECHNOLOGIES | LY400641 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophia myotonica-protein kinase (DMPK), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421164 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophia myotonica-protein kinase (DMPK), transcript variant 4 from ORIGENE TECHNOLOGIES | LY421165 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophia myotonica, WD repeat containing (DMWD) from ORIGENE TECHNOLOGIES | LY417644 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophin (DMD), transcript variant Dp40 from ORIGENE TECHNOLOGIES | LY418279 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophin (DMD), transcript variant Dp71 from ORIGENE TECHNOLOGIES | LY418275 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophin (DMD), transcript variant Dp71a from ORIGENE TECHNOLOGIES | LY418277 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophin (DMD), transcript variant Dp71ab from ORIGENE TECHNOLOGIES | LY418278 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophin (DMD), transcript variant Dp71b from ORIGENE TECHNOLOGIES | LY418276 | 100 ug | ORIGENE TECHNOLOGIES |
| Dystrophin (DMD), transcript variant Dp140b from ORIGENE TECHNOLOGIES | LY418281 | 100 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303811 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302892 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309921 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305216 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH318764 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH310631 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302743 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305939 | 10 ug | ORIGENE TECHNOLOGIES |
| HLA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH304511 | 10 ug | ORIGENE TECHNOLOGIES |
| HABP2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406545 | 1 kit | ORIGENE TECHNOLOGIES |
| HABP4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411972 | 1 kit | ORIGENE TECHNOLOGIES |
| Habp2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507547 | 1 kit | ORIGENE TECHNOLOGIES |
| Habp4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507548 | 1 kit | ORIGENE TECHNOLOGIES |
| HABP4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH311972 | 10 ug | ORIGENE TECHNOLOGIES |
| EPAS1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208604 | 1 kit | ORIGENE TECHNOLOGIES |
| EPAS1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208604BN | 1 kit | ORIGENE TECHNOLOGIES |
| EPAS1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208604LP | 1 kit | ORIGENE TECHNOLOGIES |
| EPAS1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208604RB | 1 kit | ORIGENE TECHNOLOGIES |
| EPAS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408604 | 1 kit | ORIGENE TECHNOLOGIES |
| Epas1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505259 | 1 kit | ORIGENE TECHNOLOGIES |
| Human enabled homolog (Drosophila) (ENAH), transcript variant 1 from ORIGENE TECHNOLOGIES | TP310677 | 20 ug | ORIGENE TECHNOLOGIES |
| Human enabled homolog (Drosophila) (ENAH), transcript variant 2 from ORIGENE TECHNOLOGIES | TP315455 | 20 ug | ORIGENE TECHNOLOGIES |
| DNA methyltransferase 1 associated protein 1 (DMAP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412758 | 100 ug | ORIGENE TECHNOLOGIES |
| DNA methyltransferase 1 associated protein 1 (DMAP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421951 | 100 ug | ORIGENE TECHNOLOGIES |
| DNA methyltransferase 1 associated protein 1 (DMAP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425591 | 100 ug | ORIGENE TECHNOLOGIES |
| DNA methyltransferase 1 associated protein 1 (DMAP1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421952 | 100 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L13 (RPL13), full length from ORIGENE TECHNOLOGIES | TP760197 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L27 (RPL27), full length from ORIGENE TECHNOLOGIES | TP760581 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L13 (RPL13), transcript variant 2 from ORIGENE TECHNOLOGIES | TP303412 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L30 (RPL30), full length from ORIGENE TECHNOLOGIES | TP760448 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L14 (RPL14), transcript variant 1 from ORIGENE TECHNOLOGIES | TP306766 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L14 (RPL14), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300425 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L36 (RPL36), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300054 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L38 (RPL38), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300423 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ribosomal protein L8 (RPL8), transcript variant 1 from ORIGENE TECHNOLOGIES | TP310653 | 20 ug | ORIGENE TECHNOLOGIES |